Could cause temporary or reversible harm; serious harm is unlikely.
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
| Brand name | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE |
| Generic name | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE |
| Active ingredient(s) | ALBUTEROL SULFATE, IPRATROPIUM BROMIDE |
| Distributed by / for | Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059 |
| NDC | 69097-173-53 |
| Full product label | Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53 |
| Recalling firm | Cipla USA, Inc. |
| Distribution | USA nationwide. |
| Quantity | 59244/3ml FFS packs |
| Recall initiated | 2024-03-26 |
| Report date | 2024-05-01 |
| Recall completed | 2025-07-09 |
| Recall number | D-0471-2024 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗